Compare Direxion Daily S&P 500 Bull 3X Shares (SPXL) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily S&P 500 Bull 3X Shares vs 10X Genomics Inc — how do they compare? Direxion Daily S&P 500 Bull 3X Shares trades at $270.68, while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, Direxion Daily S&P 500 Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| SPXL | TXG | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $288.04 | $45.80 |
52-Week Low | $170.20 | $11.34 |
Market Cap | — | $5.48B |
Enterprise Value | — | $5.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPXL, a leveraged ETF tracking the S&P 500, trades at $264.57, down 0.44% on the day amid broader market weakness. Technical indicators signal a bearish bias with moving averages pointing lower, though oscillators remain neutral. Recent news highlights concerns about S&P 500 valuation and AI-driven concentration risks, with the index facing pressure from chip stock declines and macroeconomic uncertainty.
The outlook hinges on S&P 500 performance, with earnings season and economic data as key catalysts. Risks include market overvaluation and sector concentration, but analyst targets suggest potential upside if bullish forecasts materialize. Investors must weigh leveraged exposure against volatility and broader index trends.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
